Exact Sciences Corporation (EXAS) Reports Q1 Loss of 8c, Beats by a Penny
Exact Sciences Corporation (NASDAQ: EXAS) reported Q1 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.12 million.